These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

347 related items for PubMed ID: 24382531

  • 1. Neonatal hyperbilirubinemia due to ABO incompatibility: does blood group matter?
    Akgül S, Korkmaz A, Yiğit S, Yurdakök M.
    Turk J Pediatr; 2013; 55(5):506-9. PubMed ID: 24382531
    [Abstract] [Full Text] [Related]

  • 2. [Efficacy and safety of intravenous immunoglobulins in the management of neonatal hyperbilirubinemia due to ABO incompatibility: a meta-analysis].
    Cortey A, Elzaabi M, Waegemans T, Roch B, Aujard Y.
    Arch Pediatr; 2014 Sep; 21(9):976-83. PubMed ID: 25125032
    [Abstract] [Full Text] [Related]

  • 3. Prediction of the development of neonatal hyperbilirubinemia in ABO incompatibility.
    Chen JY, Ling UP.
    Zhonghua Yi Xue Za Zhi (Taipei); 1994 Jan; 53(1):13-8. PubMed ID: 8173995
    [Abstract] [Full Text] [Related]

  • 4. Morbidity of ABO haemolytic disease in the newborn.
    Bhat YR, Kumar CG.
    Paediatr Int Child Health; 2012 May; 32(2):93-6. PubMed ID: 22595217
    [Abstract] [Full Text] [Related]

  • 5. Indication of Mild Hemolytic Reaction Among Preterm Infants With ABO Incompatibility.
    Yogev-Lifshitz M, Leibovitch L, Schushan-Eisen I, Taran C, Strauss T, Maayan-Metzger A.
    Pediatr Blood Cancer; 2016 Jun; 63(6):1050-3. PubMed ID: 26841084
    [Abstract] [Full Text] [Related]

  • 6. Positive Direct Antiglobulin Test: Is It a Risk Factor for Significant Hyperbilirubinemia in Neonates with ABO Incompatibility?
    Ercin S, Coskun Y, Kayas K, Kavas N, Gursoy T.
    Am J Perinatol; 2024 Mar; 41(4):505-510. PubMed ID: 34847590
    [Abstract] [Full Text] [Related]

  • 7. Does prophylactic phototherapy prevent hyperbilirubinemia in neonates with ABO incompatibility and positive Coombs' test?
    Yaseen H, Khalaf M, Rashid N, Darwich M.
    J Perinatol; 2005 Sep; 25(9):590-4. PubMed ID: 16034477
    [Abstract] [Full Text] [Related]

  • 8. Prediction of ABO hemolytic disease of the newborn using pre- and perinatal quantification of maternal anti-A/anti-B IgG titer.
    Krog GR, Donneborg ML, Hansen BM, Lorenzen H, Clausen FB, Jensen KV, Kjærbye-Thygesen A, Albertsen P, Ebbesen F, Bergholt T, Smed MK, Dziegiel MH.
    Pediatr Res; 2021 Jul; 90(1):74-81. PubMed ID: 33173174
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. An early (sixth-hour) serum bilirubin measurement is useful in predicting the development of significant hyperbilirubinemia and severe ABO hemolytic disease in a selective high-risk population of newborns with ABO incompatibility.
    Sarici SU, Yurdakök M, Serdar MA, Oran O, Erdem G, Tekinalp G, Yiğit S.
    Pediatrics; 2002 Apr; 109(4):e53. PubMed ID: 11927726
    [Abstract] [Full Text] [Related]

  • 11. ABO incompatibility: which one matters?
    Sarıcı SU.
    Turk J Pediatr; 2014 Apr; 56(2):216. PubMed ID: 24911864
    [No Abstract] [Full Text] [Related]

  • 12. [Meta analysis of the effect of immunoglobulin infusion on neonatal isoimmune hemolytic disease caused by blood group incompatibility].
    Li ZH, Wang J, Chen C.
    Zhonghua Er Ke Za Zhi; 2010 Sep; 48(9):656-60. PubMed ID: 21092522
    [Abstract] [Full Text] [Related]

  • 13. Intravenous immunoglobulin G (IVIG) therapy for significant hyperbilirubinemia in ABO hemolytic disease of the newborn.
    Miqdad AM, Abdelbasit OB, Shaheed MM, Seidahmed MZ, Abomelha AM, Arcala OP.
    J Matern Fetal Neonatal Med; 2004 Sep; 16(3):163-6. PubMed ID: 15590442
    [Abstract] [Full Text] [Related]

  • 14. Intravenous immunoglobulin in ABO and Rh hemolytic diseases of newborn.
    Nasseri F, Mamouri GA, Babaei H.
    Saudi Med J; 2006 Dec; 27(12):1827-30. PubMed ID: 17143357
    [Abstract] [Full Text] [Related]

  • 15. [Neonatal ABO incompatibility underlies a potentially severe hemolytic disease of the newborn and requires adequate care].
    Senterre T, Minon JM, Rigo J.
    Arch Pediatr; 2011 Mar; 18(3):279-82. PubMed ID: 21255989
    [Abstract] [Full Text] [Related]

  • 16. Spectrum and outcome analysis of marked neonatal hyperbilirubinemia with blood group incompatibility.
    Weng YH, Chiu YW.
    Chang Gung Med J; 2009 Mar; 32(4):400-8. PubMed ID: 19664346
    [Abstract] [Full Text] [Related]

  • 17. Significance of anti-A and anti-B isohemagglutinins in cord blood of ABO incompatible newborn infants: correlation with hyperbilirubinemia.
    Serrao PA, Modanlou HD.
    J Perinatol; 1989 Jun; 9(2):154-8. PubMed ID: 2738726
    [Abstract] [Full Text] [Related]

  • 18. Maternal IgG anti-A and anti-B titres predict outcome in ABO-incompatibility in the neonate.
    Bakkeheim E, Bergerud U, Schmidt-Melbye AC, Akkök CA, Liestøl K, Fugelseth D, Lindemann R.
    Acta Paediatr; 2009 Dec; 98(12):1896-901. PubMed ID: 19703120
    [Abstract] [Full Text] [Related]

  • 19. Risk of neonatal hyperbilirubinemia in babies born to 'O' positive mothers: a prospective cohort study.
    Kalakheti BK, Singh R, Bhatta NK, Karki A, Baral N.
    Kathmandu Univ Med J (KUMJ); 2009 Dec; 7(25):11-5. PubMed ID: 19483446
    [Abstract] [Full Text] [Related]

  • 20. Reply: To PMID 24382531.
    Akgül S, Korkmaz A.
    Turk J Pediatr; 2014 Dec; 56(2):217. PubMed ID: 24911865
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.